Key result
Pericardial effusion can present as a distinct clinical entity from acute pericarditis, and its optimal management in the absence of inflammation currently lacks solid evidence.
Why the study?
Certain clinical scenarios in pericardial syndromes present peculiarities and management challenges, particularly regarding whether optimal management of pericardial effusions without clinical or subclinical inflammation is supported by solid evidence.
Highlights the clinical distinction between acute pericarditis and chronic pericardial effusion, emphasizing the need for tailored management in non-inflammatory effusions.
Answers are grounded in this paper and cite their sources.
Differentiation of acute pericarditis from chronic effusions informs management; leaves open optimal strategies for non-inflammatory cases.
The main pericardial syndromes include acute and recurrent pericarditis, constrictive pericarditis, and chronic pericardial effusion in the absence of overt inflammation. Despite recent advances in pericardial syndromes, certain clinical scenarios depict remarkable peculiarities, and their management is often challenging for the clinician. Acute pericarditis is the most common pericardial disease and in most instances is accompanied by pericardial effusion. On the other hand, pericardial effusion may appear as a separate clinical entity occasionally characterized by absence of inflammatory markers elevation. In cases that effusions are accompanied by C-reactive protein (CRP) elevation, the administration of empiric anti-inflammatory treatment as in acute pericarditis, is the guidelines recommended approach. Conversely, the optimal management of patients with pericardial effusions in the absence of clinical or subclinical inflammation (as depicted by CRP levels and cardiac magnetic resonance findings), is not supported by solid evidence. Patients with chronic pericardial effusions should be followed in specialized centers according to tailored timelines, based on the specific clinical scenarios which should consider etiology, effusion size, disease duration and stability as regards symptoms and effusion volume. Patients should also be advised to seek medical care at any time if symptoms like chest pain, dyspnea and fatigue should appear.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a review in Pericarditis and pericardial effusion. Pericardial effusion can present as a distinct clinical entity from acute pericarditis, and its optimal management in the absence of inflammation currently lacks solid evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: